Anlon Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 54.57%
- Profit Growth 9.50%
- Ebitda -67.16%
- Net Worth -52.43%
- Total Assets 102.35%
About Anlon Lifescience
Anlon Lifescience Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 December 2016 (Eight years and two months 5 days old ). Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Shah, Meet Vachhani, and Punitkumar Rasadia serve as directors at the Company.
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33309GJ2016PTC094751
- Company No.
094751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Anlon Lifescience?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Shah  | Director | 19-Dec-2016 | Current |
| Meet Vachhani | Director | 19-Dec-2016 | Current |
| Punitkumar Rasadia | Director | 19-Dec-2016 | Current |
Financial Performance of Anlon Lifescience.
Anlon Lifescience Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 54.57% increase. The company also saw a slight improvement in profitability, with a 9.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 52.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anlon Lifescience?
In 2018, Anlon Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anlon Healthcare Private LimitedMeet Vachhani and Punitkumar Rasadia are mutual person
Adis Business Solutions Private LimitedAditya Shah is a mutual person
- Advintel Medicare Private Limited
Meet Vachhani and Punitkumar Rasadia are mutual person
- Anlon Technology Research Organization L Lp
Punitkumar Rasadia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anlon Lifescience?
Unlock and access historical data on people associated with Anlon Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anlon Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anlon Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
